
Torrent Pharmaceuticals Ltd Company Cyber Security Posture
torrentpharma.comTorrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards โnot just healthcare but lifecare.โ
TPL Company Details
torrent-pharmaceuticals-ltd
10375 employees
250237.0
325
Pharmaceutical Manufacturing
torrentpharma.com
Scan still pending
TOR_9330091
In-progress

Between 800 and 900
This score is AI-generated and less favored by cyber insurers, who prefer the TPRM score.

.png)

Torrent Pharmaceuticals Ltd Company Scoring based on AI Models
Model Name | Date | Description | Current Score Difference | Score |
---|---|---|---|---|
AVERAGE-Industry | 03-12-2025 | This score represents the average cybersecurity rating of companies already scanned within the same industry. It provides a benchmark to compare an individual company's security posture against its industry peers. | N/A | Between 800 and 900 |
Torrent Pharmaceuticals Ltd Company Cyber Security News & History
Entity | Type | Severity | Impact | Seen | Url ID | Details | View |
---|
Torrent Pharmaceuticals Ltd Company Subsidiaries

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards โnot just healthcare but lifecare.โ
Access Data Using Our API

Get company history
.png)
TPL Cyber Security News
New malware โResolverRATโ targets healthcare, pharmaceutical firms
New malware 'ResolverRAT' is targeting healthcare and pharmaceutical firms, using advanced capabilities to steal sensitive data.
Sigachi Industries establishes state-of-the-art R&D Center in Hyderabad
Sigachi Industries is establishing a state-of-the-art R&D Center in Hyderabad to enhance its Research and Development (R&D) capabilities.
India's Torrent Pharma in talks with CVC, Bain Capital for Cipla bid- sources
India's Torrent Pharmaceuticals (TORP.NS) is in talks with private equity funds CVC Capital Partners and Bain Capital to raise up to $1.5 billion to bid forย ...
Microsoft & Crowdstrike Stocks Spiral Down On Wall Street After Blue Screen Glitch Affects Global Institutions
The S&P 500 ended the week down 0.7 per cent, marking its worst result since April and its first loss in the previous three weeks.
NTPC receives favourable judgement from Delhi High Court
NTPC challenged the Arbitral Award before Hon'ble High Court of Delhi under Section 34 of The Arbitration & Conciliation Act, 1996. The Hon'bleย ...
After Ipca Laboratories, pharma major Aarti Drugs hit by ransomware attack; data leaked on dark web
Aarti Drugs Ltd. and Ipca Laboratories were hit by ransomware attacks on Sept. 9th and Sept. 10th respectively. While Aarti Drugs was hit byย ...
Pharma News: Pharma Industry News, Pharmaceutical Company News Updates
Pharma Industry News: Get the latest pharma news headlines, pharmaceutical companies news updates, latest pharma industry news videos and photos fromย ...

TPL Similar Companies

SUN PHARMA
Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread acro

MSD
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important

EMS
EMS is the leading pharmaceutical company in Brazil. Established since 45 years and with 100% national capital, the company has two industrial plants strategically placed in Sรฃo Bernardo do Campo and Hortolรขndia, in the state of Sรฃo Paulo. With a work based on daring, simplicity, excellence and res

Organon
Organon is a global healthcare company with a portfolio of therapies and products in womenโs health, biosimilars, and established medicines across a wide array of conditions and diseases. Our mission is to deliver impactful medicines and solutions for a healthier every day. This site is intended f

Celesio AG
On 12 September 2017, Celesio AG has officially announced its renaming to McKesson Europe AG, based on the shareholdersโ decision at the Annual General Meeting 2017. Documents of Celesio AG remain documents of McKesson Europe AG. More information can be found in the press release"Renaming: Celesio

Dr. Reddy's Laboratories
Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of โGood Health Canโt Waitโ, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics

Frequently Asked Questions (FAQ) on Cybersecurity Incidents
TPL CyberSecurity History Information
Total Incidents: According to Rankiteo, TPL has faced 0 incidents in the past.
Incident Types: As of the current reporting period, TPL has not encountered any cybersecurity incidents.
Total Financial Loss: The total financial loss from these incidents is estimated to be {total_financial_loss}.
Cybersecurity Posture: The company's overall cybersecurity posture is described as Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards โnot just healthcare but lifecare.โ.
Detection and Response: The company detects and responds to cybersecurity incidents through {description_of_detection_and_response_process}.
Incident Details

Incident 1: Ransomware Attack
Title: {Incident_Title}
Description: {Brief_description_of_the_incident}
Date Detected: {Detection_Date}
Date Publicly Disclosed: {Disclosure_Date}
Date Resolved: {Resolution_Date}
Type: {Type_of_Attack}
Attack Vector: {Attack_Vector}
Vulnerability Exploited: {Vulnerability}
Threat Actor: {Threat_Actor}
Motivation: {Motivation}

Incident 2: Data Breach
Title: {Incident_Title}
Description: {Brief_description_of_the_incident}
Date Detected: {Detection_Date}
Date Publicly Disclosed: {Disclosure_Date}
Date Resolved: {Resolution_Date}
Type: {Type_of_Attack}
Attack Vector: {Attack_Vector}
Vulnerability Exploited: {Vulnerability}
Threat Actor: {Threat_Actor}
Motivation: {Motivation}
Common Attack Types: As of now, the company has not encountered any reported incidents involving common cyberattacks.
Identification of Attack Vectors: The company identifies the attack vectors used in incidents through {description_of_identification_process}.
Impact of the Incidents

Incident 1: Ransomware Attack
Financial Loss: {Financial_Loss}
Data Compromised: {Data_Compromised}
Systems Affected: {Systems_Affected}
Downtime: {Downtime}
Operational Impact: {Operational_Impact}
Conversion Rate Impact: {Conversion_Rate_Impact}
Revenue Loss: {Revenue_Loss}
Customer Complaints: {Customer_Complaints}
Brand Reputation Impact: {Brand_Reputation_Impact}
Legal Liabilities: {Legal_Liabilities}
Identity Theft Risk: {Identity_Theft_Risk}
Payment Information Risk: {Payment_Information_Risk}

Incident 2: Data Breach
Financial Loss: {Financial_Loss}
Data Compromised: {Data_Compromised}
Systems Affected: {Systems_Affected}
Downtime: {Downtime}
Operational Impact: {Operational_Impact}
Conversion Rate Impact: {Conversion_Rate_Impact}
Revenue Loss: {Revenue_Loss}
Customer Complaints: {Customer_Complaints}
Brand Reputation Impact: {Brand_Reputation_Impact}
Legal Liabilities: {Legal_Liabilities}
Identity Theft Risk: {Identity_Theft_Risk}
Payment Information Risk: {Payment_Information_Risk}
Average Financial Loss: The average financial loss per incident is {average_financial_loss}.
Commonly Compromised Data Types: The types of data most commonly compromised in incidents are {list_of_commonly_compromised_data_types}.

Incident 1: Ransomware Attack
Entity Name: {Entity_Name}
Entity Type: {Entity_Type}
Industry: {Industry}
Location: {Location}
Size: {Size}
Customers Affected: {Customers_Affected}

Incident 2: Data Breach
Entity Name: {Entity_Name}
Entity Type: {Entity_Type}
Industry: {Industry}
Location: {Location}
Size: {Size}
Customers Affected: {Customers_Affected}
Response to the Incidents

Incident 1: Ransomware Attack
Incident Response Plan Activated: {Yes/No}
Third Party Assistance: {Yes/No}
Law Enforcement Notified: {Yes/No}
Containment Measures: {Containment_Measures}
Remediation Measures: {Remediation_Measures}
Recovery Measures: {Recovery_Measures}
Communication Strategy: {Communication_Strategy}
Adaptive Behavioral WAF: {Adaptive_Behavioral_WAF}
On-Demand Scrubbing Services: {On_Demand_Scrubbing_Services}
Network Segmentation: {Network_Segmentation}
Enhanced Monitoring: {Enhanced_Monitoring}

Incident 2: Data Breach
Incident Response Plan Activated: {Yes/No}
Third Party Assistance: {Yes/No}
Law Enforcement Notified: {Yes/No}
Containment Measures: {Containment_Measures}
Remediation Measures: {Remediation_Measures}
Recovery Measures: {Recovery_Measures}
Communication Strategy: {Communication_Strategy}
Adaptive Behavioral WAF: {Adaptive_Behavioral_WAF}
On-Demand Scrubbing Services: {On_Demand_Scrubbing_Services}
Network Segmentation: {Network_Segmentation}
Enhanced Monitoring: {Enhanced_Monitoring}
Incident Response Plan: The company's incident response plan is described as {description_of_incident_response_plan}.
Third-Party Assistance: The company involves third-party assistance in incident response through {description_of_third_party_involvement}.
Data Breach Information

Incident 2: Data Breach
Type of Data Compromised: {Type_of_Data}
Number of Records Exposed: {Number_of_Records}
Sensitivity of Data: {Sensitivity_of_Data}
Data Exfiltration: {Yes/No}
Data Encryption: {Yes/No}
File Types Exposed: {File_Types}
Personally Identifiable Information: {Yes/No}
Prevention of Data Exfiltration: The company takes the following measures to prevent data exfiltration: {description_of_prevention_measures}.
Handling of PII Incidents: The company handles incidents involving personally identifiable information (PII) through {description_of_handling_process}.
Ransomware Information

Incident 1: Ransomware Attack
Ransom Demanded: {Ransom_Amount}
Ransom Paid: {Ransom_Paid}
Ransomware Strain: {Ransomware_Strain}
Data Encryption: {Yes/No}
Data Exfiltration: {Yes/No}
Ransom Payment Policy: The company's policy on paying ransoms in ransomware incidents is described as {description_of_ransom_payment_policy}.
Data Recovery from Ransomware: The company recovers data encrypted by ransomware through {description_of_data_recovery_process}.
Regulatory Compliance

Incident 1: Ransomware Attack
Regulations Violated: {Regulations_Violated}
Fines Imposed: {Fines_Imposed}
Legal Actions: {Legal_Actions}
Regulatory Notifications: {Regulatory_Notifications}

Incident 2: Data Breach
Regulations Violated: {Regulations_Violated}
Fines Imposed: {Fines_Imposed}
Legal Actions: {Legal_Actions}
Regulatory Notifications: {Regulatory_Notifications}
Regulatory Frameworks: The company complies with the following regulatory frameworks regarding cybersecurity: {list_of_regulatory_frameworks}.
Ensuring Regulatory Compliance: The company ensures compliance with regulatory requirements through {description_of_compliance_measures}.
Lessons Learned and Recommendations

Incident 1: Ransomware Attack
Lessons Learned: {Lessons_Learned}

Incident 2: Data Breach
Lessons Learned: {Lessons_Learned}

Incident 1: Ransomware Attack
Recommendations: {Recommendations}

Incident 2: Data Breach
Recommendations: {Recommendations}
Key Lessons Learned: The key lessons learned from past incidents are {list_of_key_lessons_learned}.
Implemented Recommendations: The company has implemented the following recommendations to improve cybersecurity: {list_of_implemented_recommendations}.
References
Additional Resources: Stakeholders can find additional resources on cybersecurity best practices at {list_of_additional_resources}.
Investigation Status

Incident 1: Ransomware Attack
Investigation Status: {Investigation_Status}

Incident 2: Data Breach
Investigation Status: {Investigation_Status}
Communication of Investigation Status: The company communicates the status of incident investigations to stakeholders through {description_of_communication_process}.
Stakeholder and Customer Advisories

Incident 1: Ransomware Attack
Stakeholder Advisories: {Stakeholder_Advisories}
Customer Advisories: {Customer_Advisories}

Incident 2: Data Breach
Stakeholder Advisories: {Stakeholder_Advisories}
Customer Advisories: {Customer_Advisories}
Advisories Provided: The company provides the following advisories to stakeholders and customers following an incident: {description_of_advisories_provided}.
Initial Access Broker

Incident 1: Ransomware Attack
Entry Point: {Entry_Point}
Reconnaissance Period: {Reconnaissance_Period}
Backdoors Established: {Backdoors_Established}
High Value Targets: {High_Value_Targets}
Data Sold on Dark Web: {Yes/No}

Incident 2: Data Breach
Entry Point: {Entry_Point}
Reconnaissance Period: {Reconnaissance_Period}
Backdoors Established: {Backdoors_Established}
High Value Targets: {High_Value_Targets}
Data Sold on Dark Web: {Yes/No}
Monitoring and Mitigation of Initial Access Brokers: The company monitors and mitigates the activities of initial access brokers through {description_of_monitoring_and_mitigation_measures}.
Post-Incident Analysis

Incident 1: Ransomware Attack
Root Causes: {Root_Causes}
Corrective Actions: {Corrective_Actions}

Incident 2: Data Breach
Root Causes: {Root_Causes}
Corrective Actions: {Corrective_Actions}
Post-Incident Analysis Process: The company's process for conducting post-incident analysis is described as {description_of_post_incident_analysis_process}.
Corrective Actions Taken: The company has taken the following corrective actions based on post-incident analysis: {list_of_corrective_actions_taken}.
Additional Questions
General Information
Ransom Payment History: The company has {paid/not_paid} ransoms in the past.
Last Ransom Demanded: The amount of the last ransom demanded was {last_ransom_amount}.
Last Attacking Group: The attacking group in the last incident was {last_attacking_group}.
Incident Details
Most Recent Incident Detected: The most recent incident detected was on {most_recent_incident_detected_date}.
Most Recent Incident Publicly Disclosed: The most recent incident publicly disclosed was on {most_recent_incident_publicly_disclosed_date}.
Most Recent Incident Resolved: The most recent incident resolved was on {most_recent_incident_resolved_date}.
Impact of the Incidents
Highest Financial Loss: The highest financial loss from an incident was {highest_financial_loss}.
Most Significant Data Compromised: The most significant data compromised in an incident was {most_significant_data_compromised}.
Most Significant System Affected: The most significant system affected in an incident was {most_significant_system_affected}.
Response to the Incidents
Third-Party Assistance in Most Recent Incident: The third-party assistance involved in the most recent incident was {third_party_assistance_in_most_recent_incident}.
Containment Measures in Most Recent Incident: The containment measures taken in the most recent incident were {containment_measures_in_most_recent_incident}.
Data Breach Information
Most Sensitive Data Compromised: The most sensitive data compromised in a breach was {most_sensitive_data_compromised}.
Number of Records Exposed: The number of records exposed in the most significant breach was {number_of_records_exposed}.
Ransomware Information
Highest Ransom Demanded: The highest ransom demanded in a ransomware incident was {highest_ransom_demanded}.
Highest Ransom Paid: The highest ransom paid in a ransomware incident was {highest_ransom_paid}.
Regulatory Compliance
Highest Fine Imposed: The highest fine imposed for a regulatory violation was {highest_fine_imposed}.
Most Significant Legal Action: The most significant legal action taken for a regulatory violation was {most_significant_legal_action}.
Lessons Learned and Recommendations
Most Significant Lesson Learned: The most significant lesson learned from past incidents was {most_significant_lesson_learned}.
Most Significant Recommendation Implemented: The most significant recommendation implemented to improve cybersecurity was {most_significant_recommendation_implemented}.
References
Most Recent Source: The most recent source of information about an incident is {most_recent_source}.
Most Recent URL for Additional Resources: The most recent URL for additional resources on cybersecurity best practices is {most_recent_url}.
Investigation Status
Current Status of Most Recent Investigation: The current status of the most recent investigation is {current_status_of_most_recent_investigation}.
Stakeholder and Customer Advisories
Most Recent Stakeholder Advisory: The most recent stakeholder advisory issued was {most_recent_stakeholder_advisory}.
Most Recent Customer Advisory: The most recent customer advisory issued was {most_recent_customer_advisory}.
Initial Access Broker
Most Recent Entry Point: The most recent entry point used by an initial access broker was {most_recent_entry_point}.
Most Recent Reconnaissance Period: The most recent reconnaissance period for an incident was {most_recent_reconnaissance_period}.
Post-Incident Analysis
Most Significant Root Cause: The most significant root cause identified in post-incident analysis was {most_significant_root_cause}.
Most Significant Corrective Action: The most significant corrective action taken based on post-incident analysis was {most_significant_corrective_action}.
What Do We Measure?
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
